IL24 and glioma: In the study of glioma, Zhang et al. established an OV carrying IL-24/Endostatin and used MSCs as the carrier to study glioma through tail vein injection, indicating that this therapeutic system can effectively inhibit the proliferation of glioma cells in vitro and the growth of the subcutaneous glioma tumor model in vivo [93].